ClinicalTrials.Veeva

Menu

The Role of Steroids Following Selective Laser Trabeculoplasty

West Virginia University logo

West Virginia University

Status

Completed

Conditions

Glaucoma

Treatments

Drug: prednisolone acetate 1%

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

To evaluate whether or not using topical steroids after selective laser trabeculoplasty affects intraocular pressure outcomes.

Full description

Subjects undergoing bilateral SLT will be randomly assigned to use prednisolone acetate 1% in one eye four times daily with no treatment in the fellow eye, for one week following SLT. Examinations will occur at baseline, and one week, one month and three months after SLT. IOP and anterior chamber inflammation will be noted at each visit.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • glaucoma or ocular hypertension
  • need for bilateral SLT

Exclusion criteria

  • eye disease precluding accurate IOP measurement
  • contraindication to topical prednisolone acetate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems